The role of growth hormone device optimization in patient-reported outcomes: real-world evidence from South Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Ji-Eun | - |
dc.contributor.author | Lee, Kee-Hyoung | - |
dc.contributor.author | Park, Mi Jung | - |
dc.contributor.author | Yang, Seung | - |
dc.contributor.author | Kim, Eun Young | - |
dc.contributor.author | Rhie, Young-Jun | - |
dc.contributor.author | Jung, Min-Ho | - |
dc.contributor.author | Yang, Aram | - |
dc.contributor.author | Kim, Shin-Hye | - |
dc.contributor.author | Chung, Lindsey Yoojin | - |
dc.contributor.author | Ko, Su Young | - |
dc.contributor.author | Lee, Young Ju | - |
dc.contributor.author | Nedjatian, Navid | - |
dc.contributor.author | Chung, Woo Yeong | - |
dc.date.accessioned | 2022-12-20T10:40:26Z | - |
dc.date.available | 2022-12-20T10:40:26Z | - |
dc.date.created | 2022-11-30 | - |
dc.date.issued | 2021-01 | - |
dc.identifier.issn | 1743-4440 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/173265 | - |
dc.description.abstract | Background,Growth hormone (GH) treatment preference and adherence are affected by delivery device convenience, injection-site pain, confidence in correct dose administration, and device satisfaction. This survey investigated if switching device to NordiFlex (R) improved treatment experience in pediatric patients in South Korea.,Design and methods,Patients aged 4-<= 18 years were surveyed. Participants were NordiFlex (R) users who previously used NordiLet (R)/other devices. Participants compared preference, self-reported adherence, satisfaction, perceived ease of use, and device subjective benefits (across four domains: ease of use, self-efficacy, minimal disruption of daily life, positive feelings about injections) of NordiFlex (R) vs. previous device.,Results,Ninety-four patients were enrolled, of which 91.5% previously used NordiLet (R). Significantly more patients preferred, and were more satisfied with NordiFlex (R) vs. previous device; mean score: 0.65 (95% confidence interval [CI]:0.41;0.88) and 0.61 (95% CI:0.36;0.85), respectively. Participants reported greater perceived ease of use (0.49 [95% CI:0.26;0.72]) and fewer missed injections (0.20 [95% CI:0.06;0.34], with NordiFlex (R) vs. previous device. Bivariate analysis showed significant associations between preference for NordiFlex (R) and higher scores on self-efficacy, ease of use, minimal disruption of daily life, and positive feelings about injection (all p < 0.001).,Conclusion,These results suggest that improvements in device features could be associated with improved treatment experience., | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Taylor and Francis Ltd. | - |
dc.title | The role of growth hormone device optimization in patient-reported outcomes: real-world evidence from South Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yang, Seung | - |
dc.identifier.doi | 10.1080/17434440.2021.1864324 | - |
dc.identifier.scopusid | 2-s2.0-85102171733 | - |
dc.identifier.wosid | 000626397600001 | - |
dc.identifier.bibliographicCitation | EXPERT REVIEW OF MEDICAL DEVICES, v.18, no.1, pp.91 - 105 | - |
dc.relation.isPartOf | EXPERT REVIEW OF MEDICAL DEVICES | - |
dc.citation.title | EXPERT REVIEW OF MEDICAL DEVICES | - |
dc.citation.volume | 18 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 91 | - |
dc.citation.endPage | 105 | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
dc.subject.keywordPlus | Surveys | - |
dc.subject.keywordPlus | human growth hormone | - |
dc.subject.keywordPlus | human growth hormone | - |
dc.subject.keywordPlus | Bivariate analysis | - |
dc.subject.keywordPlus | Confidence interval | - |
dc.subject.keywordPlus | Device optimization | - |
dc.subject.keywordPlus | Patient-reported outcomes | - |
dc.subject.keywordPlus | Pediatric patients | - |
dc.subject.keywordPlus | Perceived ease of use | - |
dc.subject.keywordPlus | Positive feelings | - |
dc.subject.keywordPlus | Switching devices | - |
dc.subject.keywordPlus | adolescent | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | child | - |
dc.subject.keywordPlus | cross-sectional study | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | major clinical study | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | medication compliance | - |
dc.subject.keywordPlus | patient preference | - |
dc.subject.keywordPlus | patient satisfaction | - |
dc.subject.keywordPlus | patient-reported outcome | - |
dc.subject.keywordPlus | pediatric patient | - |
dc.subject.keywordPlus | South Korea | - |
dc.subject.keywordPlus | caregiver | - |
dc.subject.keywordPlus | devices | - |
dc.subject.keywordPlus | injection | - |
dc.subject.keywordPlus | multivariate analysis | - |
dc.subject.keywordPlus | patient compliance | - |
dc.subject.keywordPlus | questionnaire | - |
dc.subject.keywordPlus | self report | - |
dc.subject.keywordPlus | treatment outcome | - |
dc.subject.keywordPlus | Patient treatment | - |
dc.subject.keywordAuthor | Adherence | - |
dc.subject.keywordAuthor | burden of treatment | - |
dc.subject.keywordAuthor | growth hormone delivery device | - |
dc.subject.keywordAuthor | patient preference | - |
dc.subject.keywordAuthor | patient satisfaction | - |
dc.subject.keywordAuthor | patient-reported outcomes | - |
dc.identifier.url | https://www.tandfonline.com/doi/full/10.1080/17434440.2021.1864324 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.